Sign inJoin waitlistJoin the waitlist

Back to SLCH Consortium Pediatrics

GO

Gorkem Oztosun

Resident · Washington University/B-JH/SLCH Consortium

Credentials: ·

History

Pediatrics
Washington University/B-JH/SLCH Consortium
2026–Present
Resident
Washington University/B-JH/SLCH Consortium
Present
Çukurova University Faculty of Medicine
2022–2026

Research

Mirdametinib, an FDA-Approved MEK1/2 inhibitor for adult and pediatric NF1-associated plexiform neurofibromas
Review · Expert Opinion on Investigational Drugs · 2025 · First of 3 authors · 12 citations
MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models
Clinical Cancer Research · 2025 · 4 citations
Combined FAK and MEK inhibition suppresses chromosome 8 gain malignant peripheral nerve sheath tumors
Journal of Clinical Investigation · 2026

AH
Angela Hirbe
3 papers
Amy Armstrong
2 papers
Christine Pratilas
1 paper
Eric Hawley
1 paper · 1 as a fellow
IS
Ishita Sachdeva
1 paper · 1 as a resident
JS
Jeffrey Szymanski
1 paper
Jerod Sears
1 paper · 1 as a fellow